DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

ArQule, Inc. (NASDAQ: ARQL)

1.15 -0.04 (-3.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARQL $1.15 -3.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.20
Previous Close $1.19
Daily Range $1.14 - $1.20
52-Week Range $1.04 - $2.92
Market Cap $72.2M
P/E Ratio -2.90
Dividend (Yield) $0.00 (0.0%)
Volume 70,048
Average Daily Volume 225,773
Current FY EPS -$0.51

Sector

Healthcare

Industry

Drugs

ArQule, Inc. (ARQL) Description

A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics. Website: http://www.arqule.com/

News & Commentary Rss Feed

ARQL's Top Competitors

ARQL $1.15 (-3.36%)
Current stock: ARQL
AMGN $144.09 (4.79%)
Current stock: AMGN
GILD $106.67 (4.36%)
Current stock: GILD
BIIB $326.77 (4.93%)
Current stock: BIIB